Mayne Pharma Group's CEO is Aaron Gray, appointed in Feb 2026, has a tenure of less than a year. total yearly compensation is A$1.22M, comprised of 65.9% salary and 34.1% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth $191.05K. The average tenure of the management team and the board of directors is 4.1 years and 3.9 years respectively.
Key information
Aaron Gray
Chief executive officer
AU$1.2m
Total compensation
CEO salary percentage
65.87%
CEO tenure
less than a year
CEO ownership
0.1%
Management average tenure
4.1yrs
Board average tenure
3.9yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Aaron Gray's remuneration changed compared to Mayne Pharma Group's earnings?
Date
Total Compensation
Salary
Company Earnings
Dec 31 2025
n/a
n/a
-AU$82m
Sep 30 2025
n/a
n/a
-AU$86m
Jun 30 2025
AU$1m
AU$803k
-AU$90m
Mar 31 2025
n/a
n/a
-AU$104m
Dec 31 2024
n/a
n/a
-AU$118m
Sep 30 2024
n/a
n/a
-AU$143m
Jun 30 2024
AU$1m
AU$719k
-AU$169m
Dec 31 2023
n/a
n/a
-AU$274m
Sep 30 2023
n/a
n/a
-AU$296m
Jun 30 2023
AU$1m
AU$837k
-AU$317m
Compensation vs Market: Aaron's total compensation ($USD874.45K) is below average for companies of similar size in the US market ($USD1.59M).
Compensation vs Earnings: Aaron's compensation has been consistent with company performance over the past year.
CEO
Aaron Gray
less than a year
Tenure
AU$1,218,983
Compensation
Mr. Aaron Gray is Chief Executive Officer at Mayne Pharma Group Limited since February 20, 2026. He was Chief Financial Officer of Mayne Pharma Group Limited from August 29, 2022 to February 20, 2026. He j...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Aaron Gray
Chief Executive Officer
less than a year
AU$1.22m
0.10% $ 191.0k
Griffin Buchanan
Chief Financial Officer
no data
no data
no data
Thomas Duthy
Manager of Investor Relations
no data
no data
no data
Kimberly Parker
Executive VP & General Counsel
4.6yrs
no data
no data
Brant Schofield
Executive Vice President of Corporate Development
5.6yrs
AU$1.29m
no data
Kurt Reyes
Interim Global Head of People & Culture
less than a year
no data
no data
Daniel Moore
President of DistributeRx
6.9yrs
no data
no data
Frank Casty
Executive VP
3.6yrs
no data
no data
Tony Ramy
Executive Vice President of Women's Health
no data
no data
no data
Brenton Walter
Financial Controller
no data
no data
no data
Laura Loftus
Associate General Counsel & Company Secretary
6.4yrs
no data
no data
4.1yrs
Average Tenure
Experienced Management: MAYN.F's management team is considered experienced (4.1 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Bruce G. Robinson
Non-Executive Chairman
12yrs
AU$209.81k
0.020% $ 38.9k
Ann Custin
Independent Non-Executive Director
4.4yrs
AU$221.71k
0.026% $ 50.0k
Meghan Rivera
Non-Executive Director
less than a year
no data
no data
Jacob Ma-Weaver
Director
no data
no data
no data
David Petrie
Non-Executive Director
3.9yrs
AU$208.27k
no data
3.9yrs
Average Tenure
62.5yo
Average Age
Experienced Board: MAYN.F's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/21 03:45
End of Day Share Price
2026/08/13 00:00
Earnings
2025/12/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mayne Pharma Group Limited is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.